SANOFI

Sanofi is a healthcare company that researches, develops, manufactures, and markets therapeutic solutions worldwide. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care products for various diseases and conditions. It also offers vaccines, prescription products, and over-the-counter medicines. Sanofi has collaborations with other companies to develop new treatments and therapies. The company was formerly known as Sanofi-Aventis and changed its name in 2011. Headquartered in Paris, France, Sanofi was incorporated in 1994.

Overview

Sector

Pharmaceutical

Target Price

100.8 EUR

Current Price

85.6 EUR

Potential

18%

Strengths

Current Price to Earnings Ratio (18.84) is lower than the sector mean (81.73).
Price to book ratio (1.35) is lower than the sector mean (8.32).
The company has low debt. Net Debt to EBITDA Ratio is 0.65 and it is lower than the sector mean.
EV/EBITDA (8.56) is lower than the sector mean (21.51).
EV/EBIT (15.21) is lower than the sector mean.
Price to free cash flow (17.79) is lower than the sector mean.
Strong EBITDA Margin of 32.22%.

Weaknesses

The company have lower returns than the sector in which it operates. ROIC (9.71%) is significantly lower than the sector mean (16.32%).

Key Financial Data

Indicator	Value
PER	19.3
EV/EBITDA	8.8
Price/Free Cash Flow'	18.2
ROIC	9.7%
Net Debt/EBITDA	0.6